The study results ratifies that the liberDi’s Digital Dialysis Clinic is safe to use and feasible for a single automatic PD exchange.
The first-in-human open single arm, multi-center clinical trial was performed at two separated PD units in Israel.
liberDi presented this study results as a poster in ASN Kidney WK, WDC, USA 2019 and a Publication at PDI – Peritoneal Dialysis International.
liberDi also performed a human factor validation study evaluating all user groups:
people requiring dialysis & their caregivers and healthcare professionals such as nephrologists and dialysis nurses. The study simulated a real world environment and demonstrated that effective training can be done in as little as 90 minutes and that liberDi’s Digital Dialysis Clinic can easily be operated by anyone.